Literature DB >> 19750479

IL-33 promotes DC development in BM culture by triggering GM-CSF production.

Nobuyasu Mayuzumi1, Hironori Matsushima, Akira Takashima.   

Abstract

Short-term DC cultures generated with GM-CSF and other cytokines have markedly improved our ability to study the immunobiology of DC. Here, we tested 65 cytokines individually for their potential to promote the generation of CD11c+ cells in a murine BM culture system. In addition to several cytokines known to promote DC survival and/or growth, IL-33 was found to augment DC development time- and dose-dependently. Although the resulting CD11c+ cells generated in the presence of IL-33 exhibited a typical dendritic morphology, they expressed MHC class II molecules only at modest levels, showed negligible responses to TLR ligands, produced no detectable IL-12 p70, displayed PD-L1 and PD-L2 on the surface, and failed to activate immunologically naïve T cells efficiently. IL-33-induced expansion of CD11c+ cells was completely blocked by anti-GM-CSF mAb, and GM-CSF mRNA and protein expression in BM culture was markedly elevated by added IL-33, indicating that IL-33 promotes in vitro DC generation indirectly by a GM-CSF-dependent manner. With regard to the cellular source, IL-33-dependent GM-CSF production was observed exclusively within the CD45+/FcepsilonRI+ BM population. Not only do our results reinforce the notion that GM-CSF serves as a primary DC growth factor, but they also reveal a previously unrecognized mechanism supporting DC development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19750479      PMCID: PMC2836521          DOI: 10.1002/eji.200939472

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  45 in total

1.  Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen.

Authors:  R Klemenz; S Hoffmann; A K Werenskiold
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

2.  A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor.

Authors:  S Tominaga
Journal:  FEBS Lett       Date:  1989-12-04       Impact factor: 4.124

3.  Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

Authors:  Tatjana Pecaric-Petkovic; Svetlana A Didichenko; Sacha Kaempfer; Nicole Spiegl; Clemens A Dahinden
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

4.  Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.

Authors:  C D Reid; A Stackpoole; A Meager; J Tikerpae
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

5.  Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells.

Authors:  A S Kirshenbaum; J P Goff; S W Kessler; J M Mican; K M Zsebo; D D Metcalfe
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

6.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells.

Authors:  C Caux; C Dezutter-Dambuyant; D Schmitt; J Banchereau
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

7.  Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1.

Authors:  K Yanagisawa; T Takagi; T Tsukamoto; T Tetsuka; S Tominaga
Journal:  FEBS Lett       Date:  1993-02-22       Impact factor: 4.124

8.  CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Dirk E Smith; Dean Toy; Leandra Mfuna Endam; Martin Desrosiers; Yong-Jun Liu; Karen J Howie; Judah A Denburg; Gail M Gauvreau; Guy Delespesse
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793

9.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  28 in total

1.  An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.

Authors:  Jonathan J Cho; Joshua M Stewart; Theodore T Drashansky; Maigan A Brusko; Ashley N Zuniga; Kyle J Lorentsen; Benjamin G Keselowsky; Dorina Avram
Journal:  Biomaterials       Date:  2017-07-24       Impact factor: 12.479

Review 2.  IL-33 family members and asthma - bridging innate and adaptive immune responses.

Authors:  Clare M Lloyd
Journal:  Curr Opin Immunol       Date:  2010-11-09       Impact factor: 7.486

3.  A novel role for programmed cell death receptor ligand 2 in sepsis-induced hepatic dysfunction.

Authors:  Anne-Lise Rossi; Marilyn Le; Chun-Shiang Chung; Yaping Chen; Eleanor A Fallon; Andres Matoso; Shumin Xu; Tristen T Chun; Craig P Erickson; Alfred Ayala
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-15       Impact factor: 4.052

4.  IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Authors:  Heth R Turnquist; Zhenlin Zhao; Brian R Rosborough; Quan Liu; Antonino Castellaneta; Kumiko Isse; Zhiliang Wang; Megan Lang; Donna Beer Stolz; Xin Xiao Zheng; A Jake Demetris; Foo Y Liew; Kathryn J Wood; Angus W Thomson
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

Review 5.  IL-33/ST2 axis in inflammation and immunopathology.

Authors:  Marija Milovanovic; Vladislav Volarevic; Gordana Radosavljevic; Ivan Jovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Authors:  Hemanth Ramaprakash; Takehiko Shibata; Karen E Duffy; Ugur B Ismailoglu; Rachel M Bredernitz; Ana Paula Moreira; Ana L Coelho; Anuk M Das; Natalie Fursov; Geoffrey L Chupp; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

7.  Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.

Authors:  Donye Dominguez; Cong Ye; Zhe Geng; Siqi Chen; Jie Fan; Lei Qin; Alan Long; Long Wang; Zhuoli Zhang; Yi Zhang; Deyu Fang; Timothy M Kuzel; Bin Zhang
Journal:  J Immunol       Date:  2016-12-23       Impact factor: 5.422

8.  Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow.

Authors:  Adipong Brickshawana; Virginia Smith Shapiro; Hirohito Kita; Larry R Pease
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

9.  Neutrophil priming occurs in a sequential manner and can be visualized in living animals by monitoring IL-1β promoter activation.

Authors:  Yi Yao; Hironori Matsushima; Jennifer A Ohtola; Shuo Geng; Ran Lu; Akira Takashima
Journal:  J Immunol       Date:  2014-12-19       Impact factor: 5.422

10.  IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo.

Authors:  Kimberly D Dyer; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2012-12-11       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.